TPM3 was specifically amplified in endometrioid tumors and the gene has been shown to constitute a fusion gene with NTRK1 which belongs to the group of TRK oncogenes reported for papillary thyroid carcinoma[32]. Here, NTRK1 is linked to endometrioid tumor.